Carbapenem-resistant enterobacteriaceae (CRE)

Carbapenem-resistant enterobacteriaceae (CRE) is a topic covered in the Guide to Diagnostic Tests.

To view the entire topic, please or purchase a subscription.

Anesthesia Central is an all-in-one web and mobile solution for treating patients before, during, and after surgery. This collection of drug, procedures and test information is derived from Davis’s Drug, MGH Clinical Anesthesia Procedures, Pocket Guide to Diagnostic Tests, and MEDLINE Journals. Explore these free sample topics:

Anesthesia Central

-- The first section of this topic is shown below --

Organism

Carbapenem-resistant enterobacteriaceae (CRE)

Carbapenemase production in the Enterobacteriaceae was unknown until early 2000s. Almost all carbapenem-resistant isolates were sporadic cases of hyperproduction of a beta-lactamase (AmpC or ESBL) combined with porin loss.

In 2001, there was the first report of carbapenem-resistant Klebsiella pneumoniae ; it carried a new carbapenemase, KPC enzyme.

New Delhi metallo-beta-lactamase (NDM1) has been described in patients infected with Escherichia coli or Klebsiella pneumoniae during surgery in India and Pakistan.

Outbreaks have been seen worldwide since 2003 of OXA-48 carbapenemase in K. pneumoniae , resulting in resistance to all beta-lactams.

-- To view the remaining sections of this topic, please or purchase a subscription --